Ladostigil
A novel drug candidate for Mild Cognitive Impairment
Convenient
Once daily, oral delivery
Advanced Development Stage
A large phase 2 Randomized trial completing recruitment
© 2013 Avraham Pharma - Powered by Wordpress.
Built by 